Restenosis Rates After Drug-Eluting Stent Treatment for Stenotic Small-Diameter Renal Arteries

Jundt, Michael C.; Takahashi, Edwin A.; Harmsen, William S.; Misra, Sanjay

doi:10.1007/s00270-019-02264-z

Cited by 8 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with early bifurcation of the anterior and posterior renal arteries with a stenosis involving the bifurcation or involving an accessory renal artery pose a special challenge. [100][101][102] An example of early bifurcation stenosis is shown in Supplemental Figure S2). In this situation, kissing renal artery stents can be placed through a 7F guide catheter with 2 drug-eluting coronary stents placed sideby-side as described elsewhere.…”

Section: Accessory Renal Arteriesmentioning

confidence: 99%

“…In this situation, kissing renal artery stents can be placed through a 7F guide catheter with 2 drug-eluting coronary stents placed sideby-side as described elsewhere. [102][103][104] Approximately one-third of patients have an accessory renal artery. [103][104][105][106][107][108] These arteries are often smaller but can have stenoses that may cause hypertension.…”

Section: Accessory Renal Arteriesmentioning

confidence: 99%

See 1 more Smart Citation

Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association

Bhalla¹,

Textor²,

Beckman³

et al. 2022

Hypertension

Self Cite

View full text Add to dashboard Cite

Renovascular disease is a major causal factor for secondary hypertension and renal ischemic disease. However, several prospective, randomized trials for atherosclerotic disease failed to demonstrate that renal revascularization is more effective than medical therapy for most patients. These results have greatly reduced the generalized diagnostic workup and use of renal revascularization. Most guidelines and review articles emphasize the limited average improvement and fail to identify those clinical populations that do benefit from revascularization. On the basis of the clinical experience of hypertension centers, specialists have continued selective revascularization, albeit without a summary statement by a major, multidisciplinary, national organization that identifies specific populations that may benefit. In this scientific statement for health care professionals and the public-at-large, we review the strengths and weaknesses of randomized trials in revascularization and highlight (1) when referral for consideration of diagnostic workup and therapy may be warranted, (2) the evidence/rationale for these selective scenarios, (3) interventional and surgical techniques for effective revascularization, and (4) areas of research with unmet need.

show abstract

Section: Accessory Renal Arteriesmentioning

confidence: 99%

Section: Accessory Renal Arteriesmentioning

confidence: 99%

Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association

Bhalla¹,

Textor²,

Beckman³

et al. 2022

Hypertension

Self Cite

View full text Add to dashboard Cite

show abstract

“…In the study by Corriere et al decreased risk of RS was associated with preoperative statin use (HR = 0.35; 95% CI: 0.16-0.74; p = 0.006) and increased preoperative DBP (HR = 0.70 per 10 mm Hg increase in preoperative DBP; 95% CI: 0.49-0.99; p = 0.049) [15]. However, statins were not confirmed in the study by Jundt et al, who reported history of stroke to be an independent risk factor of RS in patients with RAS and renal impairment at baseline [35].…”

Section: Discussionmentioning

confidence: 91%

“…Vessel size is also reflected by lower patency rates. In small-diameter renal arteries (< 3.5 mm) treated with DES in patients with atherosclerotic renal artery stenosis, the 1-, 2-, and 5-year patency rates were 71%, 63%, and 38%, respectively [35].…”

Section: Discussionmentioning

confidence: 95%

Long-term outcomes and determinants of stenosis recurrence after renal artery angioplasty in hypertensive patients with renovascular disease

Rosławiecka¹,

Kabłak‐Ziembicka²,

Badacz³

et al. 2020

pwki

View full text Add to dashboard Cite

Introduction: Restenosis (RS) following percutaneous angioplasty (PTA) of renal artery stenosis (RAS) might have an unfavourable impact on renal function and blood pressure (BP) outcomes. Aim: To evaluate the prevalence and predictors of RS in patients treated with PTA for RAS, and the relationship between BP and renal function (RF) changes with RS. Material and methods: We analysed freedom from RS in 210 patients (age 64.6 ±12.8 years; range: 20-85), who underwent 248 successful stent-assisted PTAs in RAS. The change in levels of serum creatinine (SCC), estimated glomerular filtration rate (eGFR), systolic/diastolic BPs (SBP/DBP) were analysed prior to PTA, at 6-, 12-month, and final follow-up visits, and whenever RS was diagnosed. Results: RS was identified in 30 (14.3%) patients, and there were 36 (14.5%) lesions. The Kaplan-Meier RS-free survival curves in fibromuscular dysplasia, atherosclerosis, and vasculitis at 1 and 7 years were: 100% and 100%; 95.6 and 83.9%; and 71.4 and 39.7%, respectively. Patients with RS, as compared to RS-free patients, presented with less pronounced changes in respect with:

show abstract

“…Because ISR occurs more frequently in small diameter renal arteries, the off‐label use of drug‐eluting coronary artery stents has been investigated in a series of 39 stented arteries in 37 patients 13 . Average diameter of treated arteries was 3.4 ± 0.4 mm.…”

Section: Discussionmentioning

confidence: 99%

Double kiss mini‐crush technique to treat complex recurrent renal artery in‐stent restenosis

Drieghe,

Hendrickx,

De Buyzere

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

The double‐kiss mini‐crush (DKMC) technique has been successfully deployed in the past for the treatment of complex coronary lesions even for left main lesions. Our case report consists of a proof‐of‐principle that the DKMC technique can be successfully translated as well to the field of complex renal artery lesions. Insightful thinking out‐of‐the “coronary” box in concert with skillful off‐label application of coronary stenting procedures may open the gate for unprecedented opportunities for the treatment of difficult‐to‐tackle in‐stent restenosis in the renal circulation.

show abstract

Restenosis Rates After Drug-Eluting Stent Treatment for Stenotic Small-Diameter Renal Arteries

Cited by 8 publications

References 24 publications

Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association

Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association

Long-term outcomes and determinants of stenosis recurrence after renal artery angioplasty in hypertensive patients with renovascular disease

Double kiss mini‐crush technique to treat complex recurrent renal artery in‐stent restenosis

Contact Info

Product

Resources

About